Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Eden Research plc (LON:EDEN) shares were down 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a 50-day simple moving average of GBX 3.87 and a 200 day simple moving average of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Transactions at Eden Research

In other news, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). 14.02% of the stock is currently owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.